Parameter | JR11 | TATE | P |
SUVmax | |||
Primary tumor (n = 22) | 18.7 ± 17.4 | 32.1 ± 23.7 | 0.013 |
Liver metastases (n = 410) | 18.6 ± 12.5 | 27.3 ± 15.4 | <0.001 |
Bone metastases (n = 158) | 7.8 ± 5.4 | 12.5 ± 12.0 | <0.001 |
Lymph node metastases (n = 37) | 14.4 ± 10.3 | 26.3 ± 17.1 | <0.001 |
Pleural/peritoneal metastases (n = 53) | 20.2 ± 4.5 | 26.4 ± 6.8 | <0.001 |
Splenic metastases (n = 2)* | 30.6 | 23.8 | |
Tumor-to-background ratio | |||
Liver metastases (n = 410) | 7.7 ± 5.4 | 3.4 ± 2.0 | <0.001 |
Splenic metastases (n = 2)* | 6.4 | 1.4 |
↵* Statistical comparison was not conducted because of limited matched lesions.
Data are expressed as mean ± SD.